Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 2, 1999, Pages 619-625

  Meerschaert, Joann ^a   Kelly, E A Becky ^a   Mosher, Deane F ^a   Busse, William W ^a   Jarjour, Nizar N ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOSTIMULATION; INHALATION TEST; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0032970276     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.2.9806053     Document Type: Article

References (32)

1. McDonald, J. A. 1989. Fibronectin in the lung. In D. F. Mosher, editor. Fibronectin. Academic Press, San Diego. 363-393.
2. Mattoli, S., V. L. Mattoso, M. Solopcrto, L. Allegra, and A. Fasoli. 1991. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J. Allergy Clin. Immunol. 87:794-802.
3. Roman, J., and J. A. McDonald. 1991. Fibronectins. In R. G. Crystal, J. B. West, P. J. Barnes, N. S. Cherniack, and E. R. Weibel, editors. The Lung: Scientific Foundations. Raven Press, New York. 399-411.
4. Roche, W. R., J. H. Williams, R. Beasley, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1:520-524.
5. Chakir, J., M. Laviolette, M. Boutet, R. Laliberte, J. Dube, and L. P. Boulet. 1996. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab. Invest. 75:735-744.
6. Campbell, A. M., P. Chanez, J. Bousquet, I. Couret, F. B. Michel, and P. Godard. 1993. Functional characteristics of bronchial epithelium obtained by brushing from asthmatic and normal subjects. Am. Rev. Respir. Dis. 147:529-534.
7. Vignola, A. M., P. Chanez, P. Paul-Lacoste, N. Paul-Eugene, P. Godard, and J. Bousquet. 1994. Phenotypic and functional modulation of normal human alveolar macrophages by histamine. Am. J. Respir. Cell Mol. Biol. 11:456-463.
8. Vignola, A. M., A. M. Campbell, P. Chanez, P. Lacoste, F. B. Michel, P. Godard, and J. Bousquet. 1993. Activation by histamine of bronchial epithelial cells from nonasthmatic subjects. Am. J. Respir. Cell Mol. Biol. 9:411-417.
9. Mosher, D. F., and R. B. Johnson. 1983. In vitro formation of disulfide-bonded fibronectin multimers. J. Biol. Chem. 10:6595-6601.
10. Chernousov, M. A., F, J. Fogerty, V. E. Koteliansky, and D. F. Mosher. 1991. Role of the I-9 and III-1 modules of fibronectin in formation of an cxtracellular fibronectin matrix. J. Biol. Chem. 266:10851-10858.
11. Carnemolla, B., L. Borsi, L. Zardi, R. J. Owens, and F. E. Baralle. 1987. Localization of the cellular-fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E. coli. FEBS Lett. 215:269-273.
12. Yamada, K. M. 1982. Isolation of fibronectin from plasma and cells. In H. Furthmayr, editor. Immunochemistry of the Extracellular Matrix. CRC Press, Boca Raton, Ill.
13. Chai, H., R. S. Farr, L. A. Froehlich, D. A. Mathison, J. A. McLean, R. R. Rosenthal, A. L. Sheffer, S. L. Spector, and R. G. Townley. 1975. Standardization of bronchial inhalation challenge procedures. J. Allergy Clin. Immunol. 56:323-327.
14. Calhoun, W. J., N. N. Jarjour, G. J. Gleich, C. A. Stevens, and W. W. Busse. 1993. Increased airway inflammation with segmental versus aerosol antigen challenge. Am. Rev. Respir. Dis. 147:1465-1471.
15. Jarjour, N. N., W. J. Calhoun, E. A. Kelly, G. J. Gleich, L. B. Schwartz, and W. W. Busse. 1997. The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. Am. J. Respir. Crit. Care Med. 155:1515-1521.
16. Faraj, B. A., G. R. Gottlieb, V. M. Camp, M. Kutner, and P. Lolies. 1984. Development of a sensitive radioassay of histamine for in vitro allergy testing. J. Nuclear Med. 25:56-63.
17. Rennard, S. I., R. Berg, G. R. Martin, J. M. Foidart, and P. G. Robey. 1980. Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal. Biochem. 104:205-214.
18. Mosher, D. F., and E. M. Williams. 1978. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J. Lab. Clin. Med. 91:729-735.
19. Allio, A. E., and P. J. McKeown-Longo. 1988. Extracellular matrix assembly of cell-derived and plasma-derived fibronectins by substrate-attached fibroblasts. J. Cell. Physiol. 135:459-466.
20. Schultz, H. E., and J. F. Heremans. 1966. Molecular Biology of Human Proteins with Special Reference to Plasma Proteins. Elsevier, New York. 174-182.
21. Ffrench-Constant, C., and R. O. Hynes. 1989. Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo. Development 106:375-388.
22. Ffrench-Constant, C., L. Van der Water, H. F. Dvorak, and R. O. Hynes. 1989. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J. Cell Biol. 109:903-914.
23. Vartio, T., L. Laitinen, O. Narvanen, M. Cutolo, L. E. Thornell, L. Zardi, and I. Virtanen. 1987. Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J. Cell Sci. 88:419-430.
24. Sekiguchi, K., A. M. Klos, S. Hirohashi, and S. Hakomori. 1986. Human tissue fibronectin: expression of different isotypes in the adult and fetal tissues. Biochem. Biophys. Res. Commun. 141:1012-1017.
25. Rennard, S. I., and R. C. Crystal. 1981. Fibronectin in human bronchopulmonary lavage fluid: elevation in patients with interstital lung disease. J. Clin. Invest. 69:113-122.
26. Teschler, H., W. R. Pohl, A. B. Thompson, N. Konietzko, D. F. Mosher, U. Costabel, and S. I. Rennard. 1993. Elevated levels of bronchoalveolar lavage vitronectin in hypersensitivity pneumonitis. Am. Rev. Respir. Dis. 147:332-337.
27. Hynes, R. O. 1990. Fibronectins. Springer-Verlag, New York. 113-175.
28. Rennard, S. I., G. W. Hunninghake, P. B. Bitterman, and R. C. Crystal. 1981. Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc. Natl. Acad. Sci. U.S.A. 78:7147-7151.
29. Vignola, A. M., P. Chanez, G. Chippara, A. Merendino, E. Zinnanti, J. Bousquet, V. Bellia, and G. Bonsignore. 1996, Release of transforming growth factor-beta (TGF-β) and fibronectin by alveolar macrophages in airway disease. Clin. Exp. Immunol. 106:114-119.
30. Cardarelli, P. M., S. Yamagata, W. Scholz, M. A. Mosinski, and E. L. Morgan. 1991. Fibronectin augments anti-CD-3-mediated IL-2 receptor (CD25) expression on human peripheral blood lymphocytes. Cell. Immunol. 135:105-117.
31. Walsh, G. M., and A. J. Wardlaw. 1997. Eosinophil interactions with extracellular matrix proteins: effects on eosinophil function and cytokine production. In B. S. Bochner, editor. Adhesion Molecules in Allergic Disease. Marcel Dekker, New York. 187-199.
32. Walsh, G. M., F. A. Symon, and A. J. Wardlaw. 1995. Human eosinophils preferentially survive on tissue fibronectin compared with plasma fibronectin. Clin. Exp. Allergy 25:1128-1136.